Aileron Therapeutics, Inc.
PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF

Last updated:

Abstract:

Aqueous pharmaceutical formulations, for parenteral administration, comprising peptidomimetic macrocycle or a pharmaceutically acceptable salt thereof wherein the peptidomimetic macrocycle binds to MDM2 and/or MDMX proteins are disclosed. Also disclosed are methods of treating diseases and disorders using the aqueous pharmaceutical formulations disclosed herein.

Status:
Application
Type:

Utility

Filling date:

6 Nov 2020

Issue date:

30 Sep 2021